Infiltration of tumor-associated macrophages is increased in the epithelial and stromal compartments of endometrial carcinomas

International Journal of Gynecological Pathology

Volumn 32, Issue 6, 2013, Pages 576-584

  Dun, Erica C ^a   Hanley, Krisztina ^b   Wieser, Friedrich ^b   Bohman, Summer ^b   Yu, Jie ^a,c   Taylor, Robert N ^a,c  

^a Atlanta Center for Minimally Invasive Surgery and Reproductive Medicine   (United States)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

associated macrophages; CD68; Endometrial cancer; Endometrioid adenocarcinoma; Papillary serous adenocarcinoma; Prognostic indicators; TAM; Tumor

Indexed keywords

ANTINEOPLASTIC AGENT; CD68 ANTIBODY; PROTEIN ANTIBODY; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER PATIENT; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER SURGERY; CANCER TISSUE; CELL COMPARTMENTALIZATION; CELL COUNT; CELL DENSITY; CELL FUNCTION; CELL INFILTRATION; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ENDOMETRIAL TISSUE; ENDOMETRIUM; ENDOMETRIUM CANCER; ENDOMETRIUM CARCINOMA; ENDOMETRIUM HYPERPLASIA; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MAJOR CLINICAL STUDY; PREDICTIVE VALUE; PRIORITY JOURNAL; RISK FACTOR; SENSITIVITY AND SPECIFICITY; STROMA CELL; TUMOR ASSOCIATED LEUKOCYTE; TUMOR VOLUME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; DISEASE PROGRESSION; ENDOMETRIAL HYPERPLASIA; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTERECTOMY; MACROPHAGES; MIDDLE AGED; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 84886098666     PISSN: 02771691     EISSN: 15387151     Source Type: Journal    
DOI: 10.1097/PGP.0b013e318284e198     Document Type: Article

References (45)

1. Howlader N, Noone AM, Krapcho M, et al, eds. SEER Cancer Statistics Review, 1975-2009. Bethesda, MD: National Cancer Institute; 2011.
2. Surveillance, Epidemiology, and End Results (SEER) Program and the National Center for Health Statistics. Available at: http://www.seer.cancer.gov/ .
3. Schmandt RE, Iglesias DA, Co NN, et al. Understanding obesity and endometrial cancer risk: opportunities for prevention. Am J Obstet Gynecol 2011;205:518-25.
4. Karageorgi S, Hankinson SE, Kraft P, et al. Reproductive factors and postmenopausal hormone use in relation to endometrial cancer risk in the Nurses' Health Study cohort 1976-2004. Int J Cancer 2010;126:208-16.
5. Friberg E, Orsini N, Mantzoros CS, et al. Alcohol intake and endometrial cancer risk: a meta-analysis of prospective studies. Br J Cancer 2010;103:127-31.
6. Wallace AE, Gibson DA, Saunders PT, et al. Inflammatory events in endometrial adenocarcinoma. J Endocrinol 2010;206:141-57.
7. Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet 2001;357:539-45. (Pubitemid 32173595)
8. zur Hausen H. Condylomata acuminata and human genital cancer. Cancer Res 1976; 36: 794.
9. Moore PS, Chang Y. Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med 1995;332:1181-5.
10. Ekbom A, Helmick C, Zack M, et al. Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med 1990;323:1228-33. (Pubitemid 20366527)
11. Shaheen N, Ransohoff DF. Gastroesophageal reflux, Barrett esophagus, and esophageal cancer: clinical applications. JAMA 2002;287:1982-6. (Pubitemid 34309756)
12. Doll R, Peto R. Cigarette smoking and bronchial carcinoma: dose and time relationships among regular smokers and lifelong non-smokers. J Epidemiol Community Health 1978;32:303-13. (Pubitemid 9067838)
13. Selikoff IJ, Churg J, Hammond EC. Relation between exposure to asbestos and mesothelioma. N Engl J Med 1965; 272:560-5.
14. Simpson JA. Endometrial carcioma of the ovary, arising in endometrial tissue in that organ. Arch Surg 1925;10:1-72.
15. Mantovani A, Schioppa T, Porta C, et al. Role of tumor-associated macrophages in tumor progression and invasion. Cancer Metastasis Rev 2006;25:315-22. (Pubitemid 44922352)
16. Lewis CE, Pollard JW. Distinct role of macrophages in different tumor microenvironments. Cancer Res 2006;66: 605-12. (Pubitemid 43165918)
17. Mantovani A, Sozzani S, Locati M, et al. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 2002;23:549-55. (Pubitemid 35223554)
18. Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature 2008;454:436-44.
19. Caballero-Campo P, Dominguez F, Coloma J, et al. Hormonal and embryonic regulation of chemokines IL-8, MCP-1 and RANTES in the human endometrium during the window of implantation. Mol Hum Reprod 2002;8:375-84. (Pubitemid 34303246)
20. Hornung D, Ryan IP, Chao VA, et al. Immunolocalization and regulation of the chemokine RANTES in human endo-metrial and endometriosis tissues and cells. J Clin Endocriol Metab 1997;82:1621-8. (Pubitemid 27200445)
21. Allavena P, Sica A, Solinas G, et al. The inflammatory microenvironment in tumor progression: the role of tumor-associated macrophages. Crit Rev Oncol Hematol 2008;66:1-9. (Pubitemid 351324128)
22. Bingle L, Brown NJ, Lewis CE. The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 2002;196:254-65. (Pubitemid 34189413)
23. Leek RD, Landers RJ, Harris AL, et al. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999;79:991-5. (Pubitemid 29082138)
24. Lissbrant IF, Stattin P, Wikstrom P, et al. Tumor associated macrophages in human prostate cancer: relation to clinicopathological variables and survival. Int J Oncol 2000;17: 445-51.
25. Hagemann T, Wilson J, Burke F, et al. Ovarian cancer cells polarize macrophages toward a tumor-associated phenotype. J Immunol 2006;176:5023-32.
26. Heller DS, Hameed M, Cracchiolo B, et al. Presence and quantification of macrophages in squamous cell carcinoma of the cervix. Int J Gynecol Cancer 2003;13:67-70. (Pubitemid 36292728)
27. Pecorelli S. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium. Int J Gynaecol Obstet 2009;105: 103-4.
28. Espinosa I, Jose Carnicer M, Catasus L, et al. Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role. Am J Surg Pathol 2010; 34:1708-14.
29. Soeda S, Nakamura N, Ozeki T, et al. Tumor-associated macrophages correlate with vascular space invasion and myometrial invasion in endometrial carcinoma. Gynecol Oncol 2008;109:122-8.
30. Leek RD, Lewis CE, Whitehouse R, et al. Association of macrophage infiltration with angiogenesis and prognosis in invasive breast carcinoma. Cancer Res 1996;56:4625-9. (Pubitemid 26338061)
31. Coussens LM, Werb Z. Inflammation and cancer. Nature 2002;420:860-7. (Pubitemid 36019639)
32. Kats R, Al-Akoum M, Guay S, et al. Cycle-dependent expression of macrophage migration inhibitory factor in the human endometrium. Hum Reprod 2005;20:3518-25. (Pubitemid 41742537)
33. Ohno S, Ohno Y, Suzuki N, et al. Correlation of histological localization of tumor-associated macrophages with clinicopa-thological features in endometrial cancer. Anticancer Res 2004;24:3335-42. (Pubitemid 39390949)
34. Sica A, Larghi P, Mancino A, et al. Macrophage polarization in tumour progression. Semin Cancer Biol 2008;18:349-55.
35. Gordon S, Taylor PR. Monocyte and macrophage heterogeneity. Nat Rev Immunol 2005;5:953-64. (Pubitemid 41746764)
36. Lamagna C, Aurrand-Lions M, Imhof BA. Dual role of macrophages in tumor growth and angiogenesis. J Leukoc Biol 2006;80:705-13. (Pubitemid 44835885)
37. Mantovani A, Germano G, Marchesi F, et al. Cancer-promoting tumor-associated macrophages: new vistas and open questions. Eur J Immunol 2011;41:2522-5.
38. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006;124:263-6. (Pubitemid 43121975)
39. Siveen KS, Kuttan G. Role of macrophages in tumour progression. Immunol Lett 2009;123:97-102.
40. Kim MK, Kim K, Han JY, et al. Modulation of inflammatory signaling pathways by phytochemicals in ovarian cancer. Genes Nutr 2011;6:109-15.
41. Allavena P, Signorelli M, Chieppa M, et al. Anti-inflammatory properties of the novel antitumor agent yondelis (trabectedin): inhibition of macrophage differentiation and cytokine production. Cancer Res 2005;65:2964-71. (Pubitemid 40490102)
42. Sessa C, De Braud F, Perotti A, et al. Trabectedin for women with ovarian carcinoma after treatment with platinum and taxanes fails. J Clin Oncol 2005;23:1867-74. (Pubitemid 46211364)
43. Tan X, Sidell N, Mancini A, et al. Multiple anticancer activities of EF24, a novel curcumin analog, on human ovarian carcinoma cells. Reprod Sci 2010;17:931-40.
44. Singh N, Singh SM, Shrivastava P. Effect of Tinospora cordifolia on the antitumor activity of tumor-associated macrophages-derived dendritic cells. Immunopharmacol Immu-notoxicol 2005;27:1-14. (Pubitemid 40389446)
45. Joseph IB, Isaacs JT. Macrophage role in the anti-prostate cancer response to one class of antiangiogenic agents. J Natl Cancer Inst 1998;90:1648-53. (Pubitemid 28523439)